Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
BIMEDA ANIMAL HEALTH LIMITED is currently managing 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. The portfolio's prosecution is spread across 3 distinct examiners, which indicates a lack of examiner concentration for the current workload. Furthermore, the involvement of 3 distinct art units suggests that the company's patent applications are being evaluated under several different technical standards and examination guidelines within the patent office.
The busiest examiner identified in the data is PACKARD, BENJAMIN J, who is currently handling 1 busiest examiner pending office action. Since there are 3 pending office actions in total, this examiner is responsible for a minority of the active challenges facing the portfolio. This distribution across 3 distinct examiners and 3 distinct art units provides a diversified prosecution environment where individual examiner tendencies are less likely to impact the portfolio as a whole. Practitioners should prepare for varied feedback, as the ratio of examiners to art units suggests that each matter is being treated as a distinct technical inquiry.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PACKARD, BENJAMIN J | 1 | 66.7% | +15.6% |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560449 | A WATER-SOLUBLE GLASS RUMEN BOLUS | BECKHARDT, LYNDSEY MARIE | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560451 | A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE | PACKARD, BENJAMIN J | 51d overdue |
| 18560449 | A WATER-SOLUBLE GLASS RUMEN BOLUS | BECKHARDT, LYNDSEY MARIE | 15d |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1655 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560451 | A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE | PACKARD, BENJAMIN J | 1612 | §103 | Final Rejection | 51d overdue | Pending | Nov 13, 2023 |
| 18560507 | A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE CONTAINING BROMOFORM | SPAINE, ROBERT FRANKLIN | 1655 | §103Other | Final Rejection | 13d | Pending | Nov 13, 2023 |
| 18560449 | A WATER-SOLUBLE GLASS RUMEN BOLUS | BECKHARDT, LYNDSEY MARIE | 1613 | §103DP | Final Rejection | 15d | Pending | Nov 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial